Oruka Therapeutics, Inc. ORKA
- ORKA-002 — Psoriasis Phase 2
- ORKA-002 — Hidradenitis Suppurativa Phase 2
- ORKA-002 — Psoriatic Arthritis Phase 2
- ORKA-021 — Psoriasis
IL-17A (2 companies · 6 programs)
Companies with an active program directed at IL-17A.
Zura Bio Ltd ZURA
- tibulizumab — Hidradenitis Suppurativa Phase 2
- tibulizumab — Diffuse Cutaneous Systemic Sclerosis Phase 2